128 related articles for article (PubMed ID: 3471668)
21. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
[TBL] [Abstract][Full Text] [Related]
22. The affected sib method. IV. Sib trios.
Payami H; Thomson G; Motro U; Louis EJ; Hudes E
Ann Hum Genet; 1985 Oct; 49(4):303-14. PubMed ID: 3865624
[TBL] [Abstract][Full Text] [Related]
23. Ascertainment considerations in the analysis of affected sib shared haplotype data.
Ewens WJ; Shute NC; Cox NJ; Price RA; Spielman RS
Genet Epidemiol Suppl; 1986; 1():319-22. PubMed ID: 3569862
[No Abstract] [Full Text] [Related]
24. T-cell-defined DR4 subtypes as markers for type 1 diabetes.
Rowe JR; Mickelson EM; Hansen JA; MacDonald MJ; Allen CI; Gabbay KH; Yunis EJ; Sheehy MJ
Hum Immunol; 1988 May; 22(1):51-60. PubMed ID: 3260586
[TBL] [Abstract][Full Text] [Related]
25. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.
Horn GT; Bugawan TL; Long CM; Manos MM; Erlich HA
Hum Immunol; 1988 Apr; 21(4):249-63. PubMed ID: 3372263
[TBL] [Abstract][Full Text] [Related]
26. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
[TBL] [Abstract][Full Text] [Related]
27. Restriction fragment length polymorphism analysis of HLA haplotypes in families with type I diabetes mellitus.
Badenhoop K; Schwarz G; Bingley P; Lewis V; Drummond V; Gale EA; Bottazzo GF
Tissue Antigens; 1990 Jan; 35(1):32-9. PubMed ID: 1968292
[TBL] [Abstract][Full Text] [Related]
28. [Risk factors in insulin-dependent diabetes].
Deschamps I; Lestradet H; Marcelli-Barge A; Poirier JC; Cohen D; Hors J
Pathol Biol (Paris); 1986 Jun; 34(6):767-72. PubMed ID: 3531993
[TBL] [Abstract][Full Text] [Related]
29. The HLA-IDDM association: implications for etiology and pathogenesis of IDDM.
Nerup J; Mandrup-Poulsen T; Mølvig J
Diabetes Metab Rev; 1987 Jul; 3(3):779-802. PubMed ID: 2440648
[No Abstract] [Full Text] [Related]
30. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
[TBL] [Abstract][Full Text] [Related]
31. Type 1 (insulin-dependent) diabetes and the question of heterogeneity.
Barbosa J
Diabetologia; 1986 Nov; 29(11):823. PubMed ID: 3493185
[No Abstract] [Full Text] [Related]
32. Molecular approaches to the relationships between HLA and susceptibility to diseases.
Degos L; Khalil I; Blanchet O; Lepage V; Paul P; Hors J
Adv Nephrol Necker Hosp; 1992; 21():13-22. PubMed ID: 1566643
[No Abstract] [Full Text] [Related]
33. Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype.
Davis JE; Cook RG; Brown MF; Pollack MS; Van M; Rich RR
Transplant Proc; 1987 Feb; 19(1 Pt 1):851-7. PubMed ID: 3493566
[No Abstract] [Full Text] [Related]
34. Susceptibility alleles at HLA-DRB1, -DQA1, and -DQB1 loci in Ethiopian childhood insulin-dependent diabetes mellitus.
Abdulkadir J; Worku Y; Giphart MJ; Telahun M; Roep BO; Ottenhoff TH; Schreuder GM
Hum Immunol; 1994 Oct; 41(2):171-2. PubMed ID: 7860364
[No Abstract] [Full Text] [Related]
35. Heterogeneity of HLA genetic factors in IDDM susceptibility.
Martell M; Marcadet A; Moine A; Boitard C; Deschamps I; Dausset J; Bach JF; Cohen D
Immunogenetics; 1990; 31(4):233-40. PubMed ID: 1970333
[TBL] [Abstract][Full Text] [Related]
36. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients.
Kwon OJ; Brautbar C; Weintrob N; Sprecher E; Saphirman C; Bloch K; Pinhas-Hamiel O; Assah S; Vardi P; Israel S
Hum Immunol; 2001 Jan; 62(1):85-91. PubMed ID: 11165718
[TBL] [Abstract][Full Text] [Related]
37. Frequency of HLA antigens in a Brazilian type I diabetic population.
Eizirik DL; Monteiro CM; Voltarelli JC; Foss MC
Braz J Med Biol Res; 1987; 20(5):533-7. PubMed ID: 3502557
[TBL] [Abstract][Full Text] [Related]
38. The insulin gene and susceptibility to IDDM.
Cox NJ; Spielman RS
Genet Epidemiol; 1989; 6(1):65-9. PubMed ID: 2567260
[TBL] [Abstract][Full Text] [Related]
39. A synergistic three allele model for the HLA-linked components of coeliac disease predisposition.
Louis EJ; Payami H; Klitz W; Lo SK; Thomson G
Genet Epidemiol Suppl; 1986; 1():277-82. PubMed ID: 3569858
[No Abstract] [Full Text] [Related]
40. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.
Michelsen B; Lernmark A
J Clin Invest; 1987 Apr; 79(4):1144-52. PubMed ID: 2881947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
